Antigen-specific Immunotherapy in Ovarian Cancer and p53 as Tumor Antigen

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|25|3804-3811

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.25, 2012-07, pp. : 3804-3811

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Life or Death of T Cells with Antigen-Specific Receptors - Using T Cells for Cancer Adoptive Immunotherapy / Gene Therapy

By  

Current Gene Therapy, Vol. 1, Iss. 3, 2001-09 ,pp. : 253-255

Bentham Science Publishers

Access to resources Recommend Favorite

Understanding Tumor-Antigen Presentation in the New Era of Cancer Immunotherapy

By  

Current Pharmaceutical Design, Vol. 22, Iss. 41, 2016-12 ,pp. : 6234-6250

Bentham Science Publishers

Access to resources Recommend Favorite

Antigen-specific therapies in multiple sclerosis

By Giacomini Paul S   Bar-Or Amit  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 3, 2009-09 ,pp. : 551-560

Informa Healthcare

Access to resources Recommend Favorite

The Correlation of Tissue p53 Protein Overexpression and p53 Antigen in Serum of Patients with Bladder Cancer

By Gopi Kishore M.   Hamid Arif   Dwivedi U.S.   Tandon Vipul   Mahmood Mufti   Singh Harbans   Singh P.B.  

UroOncology, Vol. 2, Iss. 3, 2003-07 ,pp. : 121-128

Ashgate Publishing Ltd

Access to resources Recommend Favorite

WT1 as a Novel Target Antigen for Cancer Immunotherapy

By  

Current Cancer Drug Targets, Vol. 2, Iss. 1, 2002-03 ,pp. : 45-54

Bentham Science Publishers

Access to resources Recommend Favorite